The Scientist

» drug development and immunology

Most Recent

image: Best in Industry, 2012

Best in Industry, 2012

By | June 1, 2012

Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.

2 Comments

image: Avant-Garde Science

Avant-Garde Science

By | June 1, 2012

Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.

0 Comments

image: Delivering New Genes

Delivering New Genes

By | June 1, 2012

Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. 

0 Comments

image: Interfering with Resistance

Interfering with Resistance

By | June 1, 2012

Drug efficacy and resistance mechanisms shine a light on how drugs enter cells, which could facilitate the development of new sleeping-sickness treatments. 

0 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

image: Loss of Microtubule Regulator Blocks Sperm Maturation

Loss of Microtubule Regulator Blocks Sperm Maturation

By | May 24, 2012

New research suggests that controlling cytoskeletal dynamics in sperm accessory cells may help regulate male fertility.

0 Comments

image: US Drug Approvals Top Canada, Europe

US Drug Approvals Top Canada, Europe

By | May 18, 2012

The FDA approves drugs faster and earlier than regulatory agencies in other countries.

3 Comments

image: FDA Eases Sterility Requirements

FDA Eases Sterility Requirements

By | May 16, 2012

The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.

1 Comment

image: Approving

Approving

By | May 14, 2012

The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Eppendorf
Eppendorf
Advertisement
The Scientist
The Scientist